Source | us.nlm.vsac#0.11.0:null (v4.0.1) |
resourceType | ValueSet |
id | 2.16.840.1.113883.3.464.1003.110.11.1154 |
canonical | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1154 |
version | 20210923 |
status | active |
publisher | NCQA PHEMUR |
name | HiBVaccine4DoseSchedule |
title | HiB Vaccine (4 dose schedule) |
date | 2021-09-23T01:03:11-04:00 |
experimental | false |
Usages |
|
This value set contains 4 concepts
Code | System | Display |
120 | http://hl7.org/fhir/sid/cvx | diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |
146 | http://hl7.org/fhir/sid/cvx | Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine. |
148 | http://hl7.org/fhir/sid/cvx | Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine |
48 | http://hl7.org/fhir/sid/cvx | Haemophilus influenzae type b vaccine, PRP-T conjugate |
Produced 08 Sep 2023